What is the prevalence of Cystic Fibrosis?

Cystic Fibrosis is estimated to affect approximately 100,000 people worldwide, though the exact prevalence varies significantly by geographic region and ethnicity.

Incidence and Prevalence

In the United States and many European countries, the incidence of Cystic Fibrosis is approximately 1 in 2,500 to 3,500 live births. While often classified as a "rare" disease in global terms, it is considered one of the most common life-shortening, recessively inherited conditions in populations of Caucasian descent. Because Cystic Fibrosis is a genetic condition caused by mutations in the CFTR gene, it is present at birth, though the age of clinical diagnosis varies widely based on the severity of symptoms and the effectiveness of newborn screening programs.

Demographics and Geographic Variation

Cystic Fibrosis affects males and females with equal frequency. However, historically, some clinical data suggested that females with the condition might experience a more rapid decline in lung function, a phenomenon often referred to as the "CF gender gap." Geographically, the prevalence is highest in populations of Northern European ancestry and lowest in Asian and African populations, where the carrier frequency is significantly lower. While newborn screening has improved early detection, cases in under-resourced regions remain underdiagnosed, meaning global prevalence estimates likely underrepresent the true burden of the disease.

Real-World Insights

At DiseaseMaps.org, we have 762 individuals living with Cystic Fibrosis who have shared their journey, providing a valuable, real-world lens that complements formal epidemiological data. These patient-reported experiences highlight the transition of Cystic Fibrosis from a disease traditionally viewed as pediatric to one where the majority of patients are now adults, thanks to advancements in modulator therapies and comprehensive multidisciplinary care.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• Cystic Fibrosis Foundation (CFF) Patient Registry Data